BUSINESS
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
CNBC FinanceWednesday, August 5, 2026 at 4:18 PM
RedScroll Brief
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
RedScroll Signal
- Impact
- High
- Category
- Business
- Market relevance
- High
- Why it matters
- Corporate and market moves reprice risk and reveal where power and cash are concentrating. Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually. Investors will watch earnings, rates, and competitive positioning connected to Bank and America.
Desk copy
RedScroll Briefing
Extractive editorial brief — not a reprint of the original
What happened
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
Why it matters
Corporate and market moves reprice risk and reveal where power and cash are concentrating.
Background
CNBC Finance reported on this under business. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.
Timeline
CNBC Finance published: Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
Story is in today’s RedScroll edition. Follow the original source for updates.
Economic impact
Investors will watch earnings, rates, and competitive positioning connected to Bank and America.
More on
Related stories
- Aon CEO says insurance broker seeks to build 'premiere middle market platform' with purchase of rival USI
CNBC FinanceBUSINESS
- Crypto exchange Gemini not at fault for collapse of Earn lending program, arbitrator says
CNBC FinanceBUSINESS
- Fed Governor Cook says she's 'prepared to act' on rate hike to address inflation
CNBC FinanceBUSINESS
- Strive Adds $143 Million in Bitcoin as Treasury Firms Pile Back In
DecryptCRYPTO
- Will anybody use AI as much as coders do?
The Economist BusinessBUSINESS
- Will anybody use AI as much as coders?
The Economist BusinessBUSINESS
Source
CNBC Finance
Original reporting by CNBC Finance. RedScroll provides an extractive briefing only.